The companies have previously disclosed that 46 of 49 eligible states, as well as the District of Columbia and all eligible territories, have agreed to join the settlement. As of Feb.
ENGLEWOOD, Colo., Feb. 10, 2022 Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced the appointment of Elizabeth Varki Jobes, Esq.
Global private financial group supports the growth of development-stage biopharmaceutical company combatting cardiovascular disease, arthritis, and ageing.
Sun Pharmaceutical Industries rose 1.01% to Rs 678 after the company said that it has entered into a license agreement with Ferring Pharmaceuticals to commercialize obstetric drug, Caritec in India.Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals (Ferring), a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialize a Room Temperature Stable (RTS) formulation of obstetric drug, Caritec (Carbetocin RTS) in India.
Caritec is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth. The condition is commonly known as post-partum hemorrhage (PPH).
As per agreement terms, Sun Pharma is granted rights for co-marketing of the drugin India in the private market under the brand name Caritec. Ferring has developed the drug and received approval from the Drugs Controller General of India (DCGI) for introducing the